{"id":"https://openalex.org/W40391503","doi":"https://doi.org/10.1007/bf01646053","title":"Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivative","display_name":"Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivative","publication_year":1987,"publication_date":"1987-05-01","ids":{"openalex":"https://openalex.org/W40391503","doi":"https://doi.org/10.1007/bf01646053","mag":"40391503","pmid":"https://pubmed.ncbi.nlm.nih.gov/3610330"},"language":"en","primary_location":{"id":"doi:10.1007/bf01646053","doi":"https://doi.org/10.1007/bf01646053","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf01646053","pdf_url":null,"source":{"id":"https://openalex.org/S119914596","display_name":"Infection","issn_l":"0300-8126","issn":["0300-8126","1439-0973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infection","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036654131","display_name":"L. Maa\u00df","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Maa\u00df","raw_affiliation_strings":["Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, Frankfurt (M) 80"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","institution_ids":[]},{"raw_affiliation_string":"Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, Frankfurt (M) 80","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012824393","display_name":"M. Verho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Verho","raw_affiliation_strings":["Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, Frankfurt (M) 80"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","institution_ids":[]},{"raw_affiliation_string":"Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, Frankfurt (M) 80","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060249284","display_name":"Ramzan Rangoonwala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Rangoonwala","raw_affiliation_strings":["Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, Frankfurt (M) 80"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","institution_ids":[]},{"raw_affiliation_string":"Clinical Research, Clinical Pharmacology, Hoechst Aktiengesellschaft, Frankfurt (M) 80","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070630654","display_name":"Vitus Malerczyk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Malerczyk","raw_affiliation_strings":["Clinical Research, Biometrics, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","Clinical Research, Biometrics, Hoechst Aktiengesellschaft, Frankfurt (M) 80"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Biometrics, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","institution_ids":[]},{"raw_affiliation_string":"Clinical Research, Biometrics, Hoechst Aktiengesellschaft, Frankfurt (M) 80","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022961998","display_name":"P\u00e9ter Hajd\u00fa","orcid":"https://orcid.org/0000-0002-0885-7952","observed_orcids":["https://orcid.org/0000-0002-0885-7952"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Hajd\u00fa","raw_affiliation_strings":["Department of Biochemistry, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","Department of Biochemistry, Hoechst Aktiengesellschaft, Frankfurt (M) 80"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","institution_ids":[]},{"raw_affiliation_string":"Department of Biochemistry, Hoechst Aktiengesellschaft, Frankfurt (M) 80","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036554952","display_name":"NORBERT KLESEL","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Klesel","raw_affiliation_strings":["Department of Chemotherapy, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","Department of Chemotherapy, Hoechst Aktiengesellschaft, Frankfurt (M) 80"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemotherapy, Hoechst Aktiengesellschaft, P.O. Box 80 03 20, D-6230, Frankfurt (M) 80","institution_ids":[]},{"raw_affiliation_string":"Department of Chemotherapy, Hoechst Aktiengesellschaft, Frankfurt (M) 80","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.5349,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.78453947,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"15","issue":"3","first_page":"211","last_page":"214"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11080","display_name":"Surgical site infection prevention","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefpirome","display_name":"cefpirome","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.7250000238418579},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9129999876022339},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9409999847412109},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.7889999747276306},{"id":"https://openalex.org/keywords/biological-half-life","display_name":"biological half-life","score":0.7990000247955322},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.9129999876022339},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.8510000109672546},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.8410000205039978},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.47600001096725464},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.42800000309944153}],"concepts":[{"id":"https://openalex.org/C2777457247","wikidata":"https://www.wikidata.org/wiki/Q2943814","display_name":"Cefpirome","level":5,"score":0.990450382232666},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6901800632476807},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.6563175916671753},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6480716466903687},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.6450935006141663},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.6348181962966919},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.506899893283844},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4998142719268799},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.30044782161712646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20749437808990479},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08165663480758667},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.06459474563598633},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000097572","descriptor_name":"Cefpirome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001681","descriptor_name":"Biological Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf01646053","doi":"https://doi.org/10.1007/bf01646053","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf01646053","pdf_url":null,"source":{"id":"https://openalex.org/S119914596","display_name":"Infection","issn_l":"0300-8126","issn":["0300-8126","1439-0973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infection","raw_type":"journal-article"},{"id":"pmid:3610330","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3610330","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infection","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W320378292","https://openalex.org/W571870702","https://openalex.org/W2020210187","https://openalex.org/W2026358600","https://openalex.org/W2410184021","https://openalex.org/W2917487006"],"related_works":["https://openalex.org/W213763152","https://openalex.org/W123900060","https://openalex.org/W2061911226","https://openalex.org/W2050259485","https://openalex.org/W2405472525","https://openalex.org/W4450818","https://openalex.org/W2332735016","https://openalex.org/W2409037881","https://openalex.org/W2001918048","https://openalex.org/W2333442106"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}